Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|July 29, 2009
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegalyMarily Theodoropoulou, Maria A Tichomirowa, Caroline Sievers, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 21, 2016
Screening for genetic causes of growth hormone hypersecretionLiliya Rostomyan, Albert Beckers
European Journal of Endocrinology|May 14, 2011
Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasisElena Livadariu, Renata S Auriemma, Catherine Rydlewski, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomasAnne Barlier, Jean-François Vanbellinghen, Adrian F Daly, et al.
Medicina|February 1, 2015
[Pasqualini's syndrome: hypoandrogenism with spermatogenesis]Hernán Valdés Socin, Albert Beckers
Molecular and Cellular Endocrinology|February 14, 2016
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cellsSandra Rotondi, Alessio Modarelli, Maria-Antonietta Oliva, et al.
Treatments in Endocrinology|March 4, 2005
Lanreotide Autogel for acromegaly: a new addition to the treatment armamentariumAntonio Ciccarelli, Adrian Daly, Albert Beckers
Annales D'Endocrinologie|April 26, 2015
Parathyroid carcinoma: Challenges in diagnosis and treatmentDaniela Betea, Iulia Potorac, Albert Beckers
The Journal of Clinical Endocrinology and Metabolism|April 11, 2026
Genetics of Familial Acromegaly and Pituitary GigantismSunita M C De Sousa, Adrian F Daly
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Pageof 17